Publicacions en col·laboració amb investigadors/es de Hospital del Bierzo (89)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  2. Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study

    Clinical Drug Investigation

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

  3. Perinatal health indicators in a region of Spain corresponding to the period 2015 to 2020

    Revista Espanola de Salud Publica, Vol. 97

  4. Perinatal health indicators in a region of Spain corresponding to the period 2015 to 2020

    Revista espanola de salud publica, Vol. 97

2022

  1. Development and validation of a questionnaire for assessing patients´ perceptions of interprofessional integration in health care

    Journal of Interprofessional Care, Vol. 36, Núm. 4, pp. 538-544

  2. Juntos Ante el Peligro: Resultados de traquetomías para pacientes críticos por COVID-19, unidades multicéntricas de ORL en Castilla y León: Estudio de cohortes de más de 139 pacientes críticos COVD-19

    Revista ORL, Vol. 13, Núm. 2, pp. 65-66

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  4. Registro del Grupo NADYA-SENPE de Nutrición Enteral Domiciliaria en España: años 2018 y 2019

    Nutricion hospitalaria, Vol. 39, Núm. 1, pp. 223-229

  5. TRAF3 alterations are frequent in del-3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features

    American Journal of Hematology, Vol. 97, Núm. 7, pp. 903-914

2021

  1. Clinical and biological markers for predicting ARDS and outcome in septic patients

    Scientific Reports, Vol. 11, Núm. 1

  2. Effect of the type of specialized nutrition support on the course of the patient with amyotrophic lateral sclerosis (ALS). Interhospital registry SCLEDyN

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 10, pp. 699-707

  3. Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

    Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346

  4. Impact of percutaneous endoscopic gastrostomy (Peg) on the evolution of disease in patients with amyotrophic lateral sclerosis (als)

    Nutrients, Vol. 13, Núm. 8

  5. Methylprednisolone in adults hospitalized with COVID-19 pneumonia : An open-label randomized trial (GLUCOCOVID)

    Wiener klinische Wochenschrift, Vol. 133, Núm. 7-8, pp. 303-311

  6. Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 6, pp. 413-420

  7. Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Home and Ambulatory Artificial Nutrition (NADYA) group report. Home parenteral nutrition in Spain, 2018

    Nutricion Hospitalaria, Vol. 37, Núm. 2, pp. 403-407

  2. Prediction of poor outcome in Clostridioides difficile infection: A multicentre external validation of the toxin B amplification cycle

    Anaerobe, Vol. 61